Surrozen's collaboration agreement terminated by TCGFB for convenience, effective Nov 13

Surrozen, Inc./DE

TCGFB terminated Collaboration Agreement for convenience; no termination penalties incurred by either party.
Agreement provided Surrozen up to $6.0M in payments plus warrant for 3.4M TCGFB shares at $0.0001/share.
Collaboration was for antibody discovery services; TCGFB owned all TGF-β product IP.
TCGFB is affiliated with The Column Group, a >5% holder of Surrozen stock; board member Kutzkey is TCG Managing Partner.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.